HIMS•benzinga•
Hims & Hers Health Are Falling Today: What's Going On?
Summary
Hims & Hers Health, Inc. (NYSE: HIMS) are trading lower Thursday. The U.S. Food and Drug Administration (FDA) issued a new decision regarding the status of tirzepatide injection shortages, which have impacted the market for GLP-1 receptor agonists. Here's what you need to know.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on December 19, 2024 by benzinga